D
LifeMD, Inc.
LFMD
$4.29
-$0.38-8.14%
D
Sell
5/17/2024Upgraded
LifeMD, Inc. (LFMD) was upgraded to D- from E+ on 5/17/2024 due to an increase in the valuation index, total return index and volatility index.
LifeMD, Inc. (LFMD) was upgraded to D- from E+ on 5/17/2024 due to an increase in the valuation index, total return index and volatility index.
E
Sell
3/12/2024Downgrade
LifeMD, Inc. (LFMD) was downgraded to E+ from D- on 3/12/2024 due to a noticeable decline in the valuation index.
LifeMD, Inc. (LFMD) was downgraded to E+ from D- on 3/12/2024 due to a noticeable decline in the valuation index.
D
Sell
3/14/2023Downgrade
LifeMD, Inc. (LFMD) was downgraded to D- from D on 3/14/2023 due to a decline in the total return index and volatility index.
LifeMD, Inc. (LFMD) was downgraded to D- from D on 3/14/2023 due to a decline in the total return index and volatility index.
D
Sell
2/23/2023Upgraded
LifeMD, Inc. (LFMD) was upgraded to D from D- on 2/23/2023 due to an increase in the volatility index.
LifeMD, Inc. (LFMD) was upgraded to D from D- on 2/23/2023 due to an increase in the volatility index.
D
Sell
2/8/2023Downgrade
LifeMD, Inc. (LFMD) was downgraded to D- from D on 2/8/2023 due to a noticeable decline in the solvency index, total return index and volatility index. The quick ratio declined from 0.55 to 0.34.
LifeMD, Inc. (LFMD) was downgraded to D- from D on 2/8/2023 due to a noticeable decline in the solvency index, total return index and volatility index. The quick ratio declined from 0.55 to 0.34.
D
Sell
5/5/2022Upgraded
LifeMD, Inc. (LFMD) was upgraded to D from D- on 5/5/2022 due to an increase in the valuation index.
LifeMD, Inc. (LFMD) was upgraded to D from D- on 5/5/2022 due to an increase in the valuation index.
D
Sell
4/20/2022Downgrade
LifeMD, Inc. (LFMD) was downgraded to D- from D on 4/20/2022 due to a decline in the total return index, valuation index and volatility index.
LifeMD, Inc. (LFMD) was downgraded to D- from D on 4/20/2022 due to a decline in the total return index, valuation index and volatility index.
D
Sell
11/11/2021Upgraded
LifeMD, Inc. (LFMD) was upgraded to D from D- on 11/11/2021 due to an increase in the growth index. Operating cash flow increased 30.88% from -$10.73M to -$7.42M, EBIT increased 21.92% from -$16.13M to -$12.59M, and earnings per share increased from -$0.6402 to -$0.54.
LifeMD, Inc. (LFMD) was upgraded to D from D- on 11/11/2021 due to an increase in the growth index. Operating cash flow increased 30.88% from -$10.73M to -$7.42M, EBIT increased 21.92% from -$16.13M to -$12.59M, and earnings per share increased from -$0.6402 to -$0.54.
D
Sell
11/8/2021Downgrade
LifeMD, Inc. (LFMD) was downgraded to D- from D on 11/8/2021 due to a noticeable decline in the solvency index, volatility index and total return index.
LifeMD, Inc. (LFMD) was downgraded to D- from D on 11/8/2021 due to a noticeable decline in the solvency index, volatility index and total return index.
D
Sell
10/1/2021Downgrade
LifeMD, Inc. (LFMD) was downgraded to D from D+ on 10/1/2021 due to a significant decline in the total return index and volatility index.
LifeMD, Inc. (LFMD) was downgraded to D from D+ on 10/1/2021 due to a significant decline in the total return index and volatility index.
D
Sell
4/5/2021Upgraded
LifeMD, Inc. (LFMD) was upgraded to D+ from D on 4/5/2021 due to a substantial increase in the solvency index, volatility index and valuation index. The quick ratio increased from 0.14 to 0.73, and debt to equity declined from -0.24 to -0.34.
LifeMD, Inc. (LFMD) was upgraded to D+ from D on 4/5/2021 due to a substantial increase in the solvency index, volatility index and valuation index. The quick ratio increased from 0.14 to 0.73, and debt to equity declined from -0.24 to -0.34.
D
Sell
8/14/2020Downgrade
Conversion Labs, Inc. (CVLB) was downgraded to D from D+ on 8/14/2020 due to a large decline in the solvency index, valuation index and volatility index. The quick ratio declined from 0.14 to 0.11.
Conversion Labs, Inc. (CVLB) was downgraded to D from D+ on 8/14/2020 due to a large decline in the solvency index, valuation index and volatility index. The quick ratio declined from 0.14 to 0.11.
D
Sell
6/15/2020Upgraded
Conversion Labs, Inc. (CVLB) was upgraded to D+ from D on 6/15/2020 due to an increase in the total return index and volatility index.
Conversion Labs, Inc. (CVLB) was upgraded to D+ from D on 6/15/2020 due to an increase in the total return index and volatility index.
D
Sell
5/22/2020Downgrade
Conversion Labs, Inc. (CVLB) was downgraded to D from D+ on 5/22/2020 due to a large decline in the growth index, solvency index and volatility index. Earnings per share declined from -$0.0133 to -$0.05, EBIT declined 235.1% from -$519.4 to -$1.74M, and debt to equity increased from -0.82 to -0.18.
Conversion Labs, Inc. (CVLB) was downgraded to D from D+ on 5/22/2020 due to a large decline in the growth index, solvency index and volatility index. Earnings per share declined from -$0.0133 to -$0.05, EBIT declined 235.1% from -$519.4 to -$1.74M, and debt to equity increased from -0.82 to -0.18.
D
Sell
5/1/2020Downgrade
Conversion Labs, Inc. (CVLB) was downgraded to D+ from C- on 5/1/2020 due to a significant decline in the efficiency index.
Conversion Labs, Inc. (CVLB) was downgraded to D+ from C- on 5/1/2020 due to a significant decline in the efficiency index.
C
Hold
4/9/2020Upgraded
Conversion Labs, Inc. (CVLB) was upgraded to C- from D+ on 4/9/2020 due to a noticeable increase in the growth index, total return index and volatility index.
Conversion Labs, Inc. (CVLB) was upgraded to C- from D+ on 4/9/2020 due to a noticeable increase in the growth index, total return index and volatility index.
D
Sell
4/1/2020Upgraded
Conversion Labs, Inc. (CVLB) was upgraded to D+ from D- on 4/1/2020 due to a significant increase in the efficiency index, growth index and solvency index. Operating cash flow increased 129.01% from -$547.7 to $158.9, EBIT increased 46.66% from -$973.7 to -$519.4, and total revenue increased 26.16% from $3.13M to $3.94M.
Conversion Labs, Inc. (CVLB) was upgraded to D+ from D- on 4/1/2020 due to a significant increase in the efficiency index, growth index and solvency index. Operating cash flow increased 129.01% from -$547.7 to $158.9, EBIT increased 46.66% from -$973.7 to -$519.4, and total revenue increased 26.16% from $3.13M to $3.94M.
D
Sell
11/25/2019Downgrade
Conversion Labs, Inc. (CVLB) was downgraded to D- from D on 11/25/2019 due to a decline in the efficiency index and volatility index.
Conversion Labs, Inc. (CVLB) was downgraded to D- from D on 11/25/2019 due to a decline in the efficiency index and volatility index.
D
Sell
11/15/2019Downgrade
Conversion Labs, Inc. (CVLB) was downgraded to D from D+ on 11/15/2019 due to a significant decline in the efficiency index and solvency index. Net income declined 15.36% from -$818.1 to -$943.8.
Conversion Labs, Inc. (CVLB) was downgraded to D from D+ on 11/15/2019 due to a significant decline in the efficiency index and solvency index. Net income declined 15.36% from -$818.1 to -$943.8.
D
Sell
8/19/2019Upgraded
Conversion Labs, Inc. (CVLB) was upgraded to D+ from D on 8/19/2019 due to a significant increase in the efficiency index and valuation index.
Conversion Labs, Inc. (CVLB) was upgraded to D+ from D on 8/19/2019 due to a significant increase in the efficiency index and valuation index.
D
Sell
5/17/2019Upgraded
Conversion Labs, Inc. (CVLB) was upgraded to D from D- on 5/17/2019 due to an increase in the volatility index.
Conversion Labs, Inc. (CVLB) was upgraded to D from D- on 5/17/2019 due to an increase in the volatility index.
D
Sell
3/6/2019Upgraded
Conversion Labs, Inc. (CVLB) was upgraded to D- from E+ on 3/6/2019 due to an increase in the volatility index.
Conversion Labs, Inc. (CVLB) was upgraded to D- from E+ on 3/6/2019 due to an increase in the volatility index.
E
Sell
2/11/2019Downgrade
Conversion Labs, Inc. (CVLB) was downgraded to E+ from D- on 2/11/2019 due to a noticeable decline in the volatility index, total return index and solvency index.
Conversion Labs, Inc. (CVLB) was downgraded to E+ from D- on 2/11/2019 due to a noticeable decline in the volatility index, total return index and solvency index.
D
Sell
11/19/2018Downgrade
Conversion Labs, Inc. (CVLB) was downgraded to D- from D on 11/19/2018 due to a decline in the efficiency index, solvency index and total return index. The quick ratio declined from 1.48 to 0.83, and total capital declined 13.67% from $1.39M to $1.2M.
Conversion Labs, Inc. (CVLB) was downgraded to D- from D on 11/19/2018 due to a decline in the efficiency index, solvency index and total return index. The quick ratio declined from 1.48 to 0.83, and total capital declined 13.67% from $1.39M to $1.2M.
D
Sell
8/17/2018Downgrade
Conversion Labs, Inc. (CVLB) was downgraded to D from C- on 8/17/2018 due to a significant decline in the efficiency index, growth index and total return index. Operating cash flow declined 546.28% from $65.9 to -$294.1, earnings per share declined from $0.01 to -$0.0141, and net income declined 196.76% from $627.3 to -$607.
Conversion Labs, Inc. (CVLB) was downgraded to D from C- on 8/17/2018 due to a significant decline in the efficiency index, growth index and total return index. Operating cash flow declined 546.28% from $65.9 to -$294.1, earnings per share declined from $0.01 to -$0.0141, and net income declined 196.76% from $627.3 to -$607.
C
Hold
5/16/2018Downgrade
ImmuDyne, Inc. (IMMD) was downgraded to C- from C on 5/16/2018 due to a significant decline in the total return index, valuation index and volatility index.
ImmuDyne, Inc. (IMMD) was downgraded to C- from C on 5/16/2018 due to a significant decline in the total return index, valuation index and volatility index.
C
Hold
10/5/2017Upgraded
ImmuDyne, Inc. (IMMD) was upgraded to C from C- on 10/5/2017 due to a noticeable increase in the total return index, growth index and volatility index. Total revenue increased 160.87% from $424.5 to $1.11M, earnings per share increased from -$0.03 to $0.0181, and operating cash flow increased 91.7% from -$473.3 to -$39.3.
ImmuDyne, Inc. (IMMD) was upgraded to C from C- on 10/5/2017 due to a noticeable increase in the total return index, growth index and volatility index. Total revenue increased 160.87% from $424.5 to $1.11M, earnings per share increased from -$0.03 to $0.0181, and operating cash flow increased 91.7% from -$473.3 to -$39.3.
C
Hold
7/7/2017Downgrade
ImmuDyne, Inc. (IMMD) was downgraded to C- from C on 7/7/2017 due to a significant decline in the total return index, solvency index and growth index. Debt to equity increased from -0.58 to -0.02, earnings per share declined from -$0.0162 to -$0.03, and operating cash flow declined 59.79% from -$296.2 to -$473.3.
ImmuDyne, Inc. (IMMD) was downgraded to C- from C on 7/7/2017 due to a significant decline in the total return index, solvency index and growth index. Debt to equity increased from -0.58 to -0.02, earnings per share declined from -$0.0162 to -$0.03, and operating cash flow declined 59.79% from -$296.2 to -$473.3.
C
Hold
5/25/2017Upgraded
ImmuDyne, Inc. (IMMD) was upgraded to C from D on 5/25/2017 due to a significant increase in the efficiency index, valuation index and solvency index. Debt to equity declined from 0.71 to -0.58.
ImmuDyne, Inc. (IMMD) was upgraded to C from D on 5/25/2017 due to a significant increase in the efficiency index, valuation index and solvency index. Debt to equity declined from 0.71 to -0.58.
D
Sell
5/18/2016Upgraded
ImmuDyne, Inc. (IMMD) was upgraded to D from D- on 5/18/2016 due to a significant increase in the total return index, solvency index and volatility index.
ImmuDyne, Inc. (IMMD) was upgraded to D from D- on 5/18/2016 due to a significant increase in the total return index, solvency index and volatility index.
D
Sell
3/31/2016Downgrade
ImmuDyne, Inc. (IMMD) was downgraded to D- from C on 3/31/2016 due to a significant decline in the efficiency index, growth index and valuation index. EBIT declined 1,612.85% from $17.9 to -$270.8, operating cash flow declined 798.74% from -$23.9 to -$214.8, and net income declined 725.93% from $8.1 to -$50.7.
ImmuDyne, Inc. (IMMD) was downgraded to D- from C on 3/31/2016 due to a significant decline in the efficiency index, growth index and valuation index. EBIT declined 1,612.85% from $17.9 to -$270.8, operating cash flow declined 798.74% from -$23.9 to -$214.8, and net income declined 725.93% from $8.1 to -$50.7.
C
Hold
3/28/2016Upgraded
ImmuDyne, Inc. (IMMD) was upgraded to C from C- on 3/28/2016 due to a noticeable increase in the total return index and volatility index.
ImmuDyne, Inc. (IMMD) was upgraded to C from C- on 3/28/2016 due to a noticeable increase in the total return index and volatility index.
C
Hold
3/11/2016Downgrade
ImmuDyne, Inc. (IMMD) was downgraded to C- from C on 3/11/2016 due to a significant decline in the volatility index, valuation index and total return index.
ImmuDyne, Inc. (IMMD) was downgraded to C- from C on 3/11/2016 due to a significant decline in the volatility index, valuation index and total return index.
C
Hold
3/31/2015Upgraded
ImmuDyne, Inc. (IMMD) was upgraded to C from D+ on 3/31/2015 due to a significant increase in the efficiency index, volatility index and growth index. Net income increased 38.69% from -$103.9 to -$144.1, earnings per share increased from -$0.0034 to -$0.0047, and EBIT increased 9.03% from -$132.9 to -$144.9.
ImmuDyne, Inc. (IMMD) was upgraded to C from D+ on 3/31/2015 due to a significant increase in the efficiency index, volatility index and growth index. Net income increased 38.69% from -$103.9 to -$144.1, earnings per share increased from -$0.0034 to -$0.0047, and EBIT increased 9.03% from -$132.9 to -$144.9.
D
Sell
1/29/2015Upgraded
ImmuDyne, Inc. (IMMD) was upgraded to D+ from D on 1/29/2015 due to a noticeable increase in the valuation index and volatility index.
ImmuDyne, Inc. (IMMD) was upgraded to D+ from D on 1/29/2015 due to a noticeable increase in the valuation index and volatility index.
D
Sell
6/9/2014Downgrade
ImmuDyne, Inc. (IMMD) was downgraded to D from D+ on 6/9/2014 due to a significant decline in the volatility index, total return index and growth index. Operating cash flow declined 95.5% from -$146.6 to -$6.6, and EBIT declined 38.08% from -$286.8 to -$177.6.
ImmuDyne, Inc. (IMMD) was downgraded to D from D+ on 6/9/2014 due to a significant decline in the volatility index, total return index and growth index. Operating cash flow declined 95.5% from -$146.6 to -$6.6, and EBIT declined 38.08% from -$286.8 to -$177.6.
NASDAQ
03/10/2025 3:13PM Eastern
Quotes delayed
